Dr. Angela Stewart -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Angela Stewart, a Dermatology physician based in San Antonio, TX. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Angela Stewart has received $4,893.24 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Angela Stewart has received a total of $4,893.24 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $4,893.24 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Angela Stewart's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Travel & Lodging$4,893.24Transportation and hotel expenses for conferences and meetings

The largest payment category for Dr. Angela Stewart is Travel & Lodging, accounting for 100% ($4,893.24) of total pharmaceutical payments received. This represents the primary type of financial relationship between Dr. Angela Stewart and pharmaceutical companies.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Angela Stewart. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Novartis Pharmaceuticals$4,893.241

Dr. Angela Stewart has a financial relationship with Novartis Pharmaceuticals, receiving $4,893.24 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Angela Stewart's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Angela Stewart has received $4.9K across 1 pharmaceutical payments as a Dermatology physician in San Antonio, TX. Top paying companies include Novartis Pharmaceuticals ($4.9K). Dr. Stewart received a single payment of $4,893 in 2025, which is the entirety of her reported pharma payments. This payment was exclusively for travel expenses, indicating a specific type of engagement. The entire amount came from a single company, Novartis Pharmaceuticals, suggesting a concentrated relationship.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Angela Stewart is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers seeking information about their dermatologist's financial ties should note that this profile shows a single, specific travel-related payment from Novartis Pharmaceuticals. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Angela Stewart Compares to Other Dermatology Physicians

For a dermatologist, receiving a single, significant travel payment from a pharmaceutical company is not uncommon, though the concentration from one company is notable.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Angela Stewart in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Novartis Pharmaceuticals$4,893.24travelN/A2025-02-26Not Assessed

Frequently Asked Questions About Dr. Angela Stewart's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Angela Stewart received?

Angela Stewart has received a total of $4.9K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Angela Stewart taking too much pharma money?

Angela Stewart has received $4.9K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Dermatology), the types of payments, and how they compare to peers. The largest payment category is travel ($4.9K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Angela Stewart?

The top pharmaceutical companies paying Angela Stewart are: Novartis Pharmaceuticals ($4.9K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Angela Stewart receive?

Angela Stewart's payments by type: travel: $4.9K.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Angela Stewart's payments compare to other Dermatology doctors?

To compare, look at the total amount ($4.9K), number of payments (1), and the types of payments received. Dermatology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Angela Stewart's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1827729463). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Angela Stewart's pharma payment profile?

The doctor's payment profile is very narrow, with only one payment, one company, and one payment type recorded. Angela Stewart has received $4.9K in total pharma payments.

How does Angela Stewart compare to peers in Dermatology?

For a dermatologist, receiving a single, significant travel payment from a pharmaceutical company is not uncommon, though the concentration from one company is notable.

Are Angela Stewart's pharma relationships typical for Dermatology?

The high average payment ($4,893) is solely due to this single, substantial travel expense.

What should patients of Angela Stewart know about these payments?

Consumers seeking information about their dermatologist's financial ties should note that this profile shows a single, specific travel-related payment from Novartis Pharmaceuticals.

What patterns are visible in Angela Stewart's payment history?

The 100% top company concentration highlights a singular relationship with Novartis Pharmaceuticals.

Understanding This Doctor Payment Report

This transparency report for Dr. Angela Stewart is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Angela Stewart's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Angela Stewart and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.